Ki-bae J. Seung - Publications

Effectiveness and safety of a shortened oral regimen for rifampicin- or multidrug-resistant TB.

Journal: IJTLD open

Published: August 29, 2025

Effectiveness of a bedaquiline, linezolid, clofazimine 'core' for multidrug-resistant TB.

Journal: IJTLD open

Published: October 02, 2024

Low body mass index as a predictor of sputum culture conversion and treatment outcomes among patients receiving treatment for multidrug-resistant tuberculosis in Lesotho.

Journal: Global health action

Published: February 02, 2024

Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.

Journal: Trials

Published: June 30, 2023

Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: May 26, 2023

Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: February 28, 2023

Long-term use of renin-angiotensin-system inhibitors after acute myocardial infarction is not associated with survival benefits: Analysis of data from the Korean acute myocardial infarction registry-national institutes of health registry.

Journal: Frontiers in cardiovascular medicine

Published: July 14, 2022

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial.

Journal: Lancet (London, England)

Published: June 04, 2021

Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial.

Journal: Trials

Published: March 08, 2021

Introducing new and repurposed TB drugs: the endTB experience.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: October 31, 2020

Setting up pharmacovigilance based on available endTB Project data for bedaquiline.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: October 31, 2020

A prospective, multicentre, randomised, open-label trial to compare the efficacy and safety of clopidogrel versus ticagrelor in stabilised patients with acute myocardial infarction after percutaneous coronary intervention: rationale and design of the TALOS-AMI trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: July 29, 2020